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Abstract
Background: A relative newcomer to the field of psychology, e-mental health has been gaining momentum and has been given
considerable research attention. Although several aspects of e-mental health have been studied, 1 aspect has yet to receive attention:
the structure of comorbidity of psychological disorders and their relationships with measures of psychosocial adjustment including
suicidal ideation in online samples.
Objective: This exploratory study attempted to identify the structure of comorbidity of 21 psychological disorders assessed by
an automated online electronic psychological assessment screening system (e-PASS). The resulting comorbidity factor scores
were then used to assess the association between comorbidity factor scores and measures of psychosocial adjustments (ie,
psychological distress, suicidal ideation, adequate social support, self-confidence in dealing with mental health issues, and quality
of life).
Methods: A total of 13,414 participants were assessed using a complex online algorithm that resulted in primary and secondary
Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) diagnoses for 21 psychological disorders
on dimensional severity scales. The scores on these severity scales were used in a principal component analysis (PCA) and the
resulting comorbidity factor scores were related to 4 measures of psychosocial adjustments.
Results: A PCA based on 17 of the 21 psychological disorders resulted in a 4-factor model of comorbidity: anxiety-depression
consisting of all anxiety disorders, major depressive episode (MDE), and insomnia; substance abuse consisting of alcohol and
drug abuse and dependency; body image–eating consisting of eating disorders, body dysmorphic disorder, and obsessive-compulsive
disorders; depression–sleep problems consisting of MDE, insomnia, and hypersomnia. All comorbidity factor scores were
significantly associated with psychosocial measures of adjustment (P<.001). They were positively related to psychological distress
and suicidal ideation, but negatively related to adequate social support, self-confidence, and quality of life.
Conclusions: This exploratory study identified 4 comorbidity factors in the e-PASS data and these factor scores significantly
predicted 5 psychosocial adjustment measures.
Trial Registration: Australian and New Zealand Clinical Trials Registry ACTRN121611000704998;
http://www.anzctr.org.au/trial_view.aspx?ID=336143 (Archived by WebCite at http://www.webcitation.org/618r3wvOG).
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Introduction
Background
The co-occurrence of multiple psychological disorders
(comorbidity) is a common and serious problem that needs to
be better researched and understood. Kessler et al [1] found the
lifetime prevalence of any disorder to be 46.4%, whereas 27.7%
and 17.3% were the lifetime prevalences of 2 or more and 3 or
more disorders, respectively. Kessler et al [2] found the
12-month prevalence of any disorder be 26.2%, whereas 5.8%
met the criteria for 2 disorders and 6.0% met the criteria for
more than 2 disorders. They also concluded that more than 40%
of those who received 1 diagnosis also met the diagnostic criteria
for a second diagnosis over a 12-month period [2]. Naturally,
those suffering from multiple psychological disorders would
more likely require greater assistance from their therapists
should they seek help. Indeed, several studies concluded that
comorbidity was consistently related to poor prognosis, higher
rate of suicide, and high demand for professional help [3,4]. In
addition, comorbidity has also been shown to be strongly related
to symptom severity [2].
Although comorbidity has been studied extensively over the
past 30 years, most studies on the structure of comorbidity have
used 6-12 disorders at most and recommended that future
research should include more disorders [5,6]. Furthermore, the
use of dimensional rather than a discrete or dichotomous
approach was suggested to solve the problems of generalizability
and detection of the correlates of more severe mental disorders
[7]. In addition, avoiding the reliance on threshold diagnoses
in favor of consideration of subthreshold information has been
recommended [8].
Krueger [7] argued for using a dimensional rather than a
discrete/dichotomous approach and for including patients who
met the criteria for multiple disorders when studying the
structure of comorbidity because such patients were typical and
more severely impaired. Consequently, Krueger argued that
basing research designs on such samples would increase
generalizability and the detection of correlates of more severe
mental disorders. To this end, Krueger performed factor analysis
on 10 mental disorders based on the Diagnostic and Statistical
Manual of Mental Disorders (Third Edition, Revised;
DSM-III-R) using the National Comorbidity Survey (NCS)
sample of 8098 (collected between 1990 and 1992) and found
2 factors: an externalizing factor which included alcohol and
drug dependency and antisocial personality disorder and an
internalizing factor which was broken down into an
anxious-misery factor, including depression, dysthymia,
generalized anxiety disorder (GAD); and a fear factor, including
social anxiety disorder (SAD), simple/specific phobia,
agoraphobia, and panic disorder (PD). This model was criticized
for the restricted range of 10 disorders, the reliance on lifetime
diagnoses, and the exclusive reliance on threshold diagnoses
without consideration of the subthreshold diagnostic information
[8]. However, the structure of Krueger’s factors was later
supported by several studies [2,6,9-12].
To review the literature on the comorbidity and the structure of
comorbidity of all 21 disorders will require a great deal of space
and is beyond the scope of this report. Therefore, we shall limit
this summary review to disorders that have received the most
attention and are the most prevalent: anxiety disorders, major
depressive disorder (MDD), eating disorders, and alcohol and
drug abuse and dependency disorders.
Anxiety and Major Depressive Disorders
Comorbidity of anxiety disorders and MDD is among the most
prevalent comorbid psychiatric conditions [13,14]. Estimates
of comorbid anxiety disorders and MDD range from 15.9% to
61.9% in children and adolescents [15] and from 14.5% [16] to
57% [17-20] in specific populations of adults. In addition, sleep
problems such as insomnia and hypersomnia have been
consistently found to be associated with anxiety and mood
disorders [21-25]. These studies suggest the existence of an
anxiety-depression-insomnia comorbidity factor.
The co-occurrence of MDD and anxiety disorders has many
clinical implications. Several studies found outpatients with
MDD and at least 1 co-occurring anxiety disorder were
significantly more likely to suffer from insomnia [21],
personality disorders [26], more severe and chronic depression
[16,27], and engage in suicidal ideation [18] and suicidal
behavior [28] than individuals with only a MDD diagnosis.
GAD is highly correlated with mood disorders and has slightly
lower correlations with anxiety disorders [29]. The tendency
for GAD to be highly comorbid with other anxiety and
depressive disorders has led some researchers to question its
discriminant validity among diagnostic categories [30].
Researchers have pointed out that some of the core features of
GAD are usually present in varying degrees in all anxiety
disorders as well as mood disorders, detracting from the overall
discriminant validity and reliability of GAD as a principal
diagnosis. Factor analysis has also revealed a closer link between
GAD and depressive disorders such as major depression,
dysthymia, and major depressive episode (MDE) (the
internalizing anxious-misery dimension) than between GAD
and anxiety disorders such as social phobia, simple/specific
phobia, PD, agoraphobia, and obsessive-compulsive disorder
(OCD)—the internalizing fear dimension [5,6]. Some
researchers suggested that GAD would be better categorized
with the mood disorders whereas others suggested a complete
revision of the hierarchical structure of the DSM-IV in which
all anxiety and mood disorders would be grouped together and
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then partitioned into 3 subclasses with MDD, GAD, dysthymic
disorder, and posttraumatic stress disorder (PTSD) forming a
subclass of distress disorders [31-33].
Conversely, a more recent longitudinal study supported the
DSM-IV-TR classification of GAD as an anxiety disorder. In an
effort to determine whether GAD would be better classified as
a mood disorder rather than an anxiety disorder, Beesdo et al
[34] examined the risk patterns, incidence, developmental
features, and comorbidity of anxiety and depressive disorders
in 3021 individuals in a prospective longitudinal study conducted
over a period of more than 10 years. They concluded that GAD
was linked more closely to anxiety disorders than mood
disorders in terms of risk associations in familial, temperamental,
personality, and environmental variables. Moreover, temporal
comorbidity of GAD showed a strong association between GAD
and other anxiety disorders.
One of the earliest reviews of the literature on comorbidity
among anxiety disorders is the one conducted by Brown and
Barlow [30]. They highlighted several points: diagnoses of PD
with or without agoraphobia and GAD were associated with
some of the highest comorbidity rates between psychiatric
conditions, core features of PD with or without agoraphobia
and GAD were shared to some extent with all anxiety disorders,
and substance abuse followed by GAD were the most commonly
comorbid lifetime and current disorders experienced by war
veterans with or without PTSD. They also concluded that, as
with GAD, the discriminant validity of PD with or without
agoraphobia was questionable because some of the central
features in PD with or without agoraphobia (eg, anxious
apprehension) were present in varying degrees in all anxiety
and mood disorders. Subsequent studies found essentially the
same associations and comorbidities—PD frequently co-occurs
with other anxiety disorders [35-37].
Depression, Anxiety, and Eating Disorders
Depressive and anxiety disorders are also frequently reported
in those diagnosed with eating disorders. The lifetime prevalence
of major depression ranges from 50% to 71% in anorexia
nervosa and 50% to 65% in bulimia nervosa [38-41]. When the
age was restricted to 12-18 years, 60% of adolescent girls with
anorexia nervosa reported comorbid mood disorder [42]. On
the other hand, when the age was broadened to include persons
aged 11-68 years, 92% of the large female sample with anorexia
nervosa had unipolar depression [43].
Although studies investigating the relationship between eating
and anxiety disorders have produced somewhat mixed results
[44-46], several researchers have found high rates of
comorbidity between eating and anxiety disorders [43,47-50].
The few studies that employed control groups found significant
comorbidity between anxiety disorders and anorexia nervosa
and bulimia nervosa populations in comparison to non-eating
disordered controls [46,51-54].
Moreover, Allen and Hollander [55] and Cororve and Gleaves
[56] pointed out the significant overlap between the features of
eating disorders (particularly anorexia nervosa) and body
dysmorphic disorder (BDD). In both cases, body image
distortion, excessive concerns and unreasonable preoccupation
about physical appearance, and stressful dissatisfaction with
one’s body are common features. Moreover, similar to the
behaviors of individuals with OCD, excessive concerns and
preoccupation over one’s body lead to anxiety-provoking
obsessive thoughts about one’s self-image which might force
the individual to engage in ritualistic-like behaviors to reduce
the generated anxiety [55,57,58]. Therefore, all these studies
suggest the existence of an eating-anxiety comorbidity factor
and/or a body image-eating disorder comorbidity factor.
Anxiety and Substance Abuse and Dependency
Disorders
The relationship between psychological disorders and the use
of drugs and alcohol has long been established [59-61].
McGovern et al [62] found substance use disorders were present
in 42%, 27%, and 20% of patients diagnosed with mood
disorders, anxiety disorders, and antisocial personality disorder,
respectively. Krueger [7] found alcohol and drug dependence
and antisocial personality disorder to make up the externalizing
factor. Katz et al [63] performed confirmatory factor analysis
on the same NCS sample used by Krueger [7], but this time
with the inclusion of alcohol and drug abuse and dependence.
They found alcohol and drug abuse to have strong negative
loadings, whereas alcohol and drug dependency were found to
have strong positive loadings on the externalizing factor. In
addition, they found alcohol and drug abuse to have substantial
loadings on the anxious-misery subfactor of the internalizing
factor. They concluded that there appears to be a group of
individuals with alcohol and drug abuse that is distinct in terms
of comorbidity patterns and etiology from those with alcohol
and drug dependency and from those with anxious-misery
disorders (MDE, dysthymia, GAD). There appears to be some
support, at least as far as alcohol is concerned, for the distinction
between alcohol abusers and alcohol dependents in that, unlike
abusers, alcohol dependency consists of a single latent
dimension whereas alcohol abuse consists of many underlying
latent dimensions [64]. These studies suggest the presence of a
substance dependence comorbidity factor.
In summary, it appears that comorbidity of psychological
disorders is a prevalent phenomenon with almost half of those
receiving a diagnosis also receiving multiple diagnoses.
Comorbidity is associated with more demands for services,
poorer prognosis, higher rate of suicide, greater levels of
severity, and poorer adjustment. Most studies on the structure
of comorbidity focused on a few psychological disorders.
Anxiety disorders, MDD, and eating disorders are the most
widely researched. Results show that comorbidity of anxiety
and MDDs are most prevalent. MDD was comorbid with GAD,
OCD, PTSD, PD with or without agoraphobia, SAD,
simple/specific phobia, insomnia, hypersomnia, and alcohol
and drug abuse disorders. Anxiety disorders are particularly
comorbid with GAD as well as with one another. In addition,
significant comorbidity has been found between anxiety,
depression, and eating disorders. Finally, although alcohol and
drug abuse disorders appear to be comorbid with MDE and
some anxiety disorders, alcohol and drug dependency disorders
form a separate group with antisocial personality disorder.
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The Mental Health Online (previously Anxiety Online)
electronic psychological assessment screening system (e-PASS;
an online psychological assessment screening system assessing
for 21 DSM-IV-TR disorders) dataset (see [65,66] for further
information), contains information on more than 13,000
individuals who have received 21 single and/or multiple
psychological diagnoses based on dimensional measures referred
to as clinical disorder severity scales. These elements of the
e-PASS dataset provide a unique opportunity to examine the
structure of comorbidity of 21 psychological disorders based
on dimensional scales that reflect information that covers
subthreshold to postthreshold diagnoses.
The purpose of this exploratory study was 2-fold. Firstly, we
used the dimensional severity scales of the e-PASS data to
explore the underlying structural dimensions of comorbidity
(henceforth, comorbidity factors) of the 21 psychological
disorders diagnosed by the e-PASS part of the Mental Health
Online platform (Figure 1) [67]. Secondly, we validated the
resulting comorbidity factors by determining their relative
performance for predicting psychological distress as measured
by Kessler-6 total score, suicidal ideation, quality of life, level
of self-confidence, and adequate social support. We predicted
that comorbidity factor scores would be positively related to
suicidal ideation and Kessler-6 total score, but negatively related
to quality of life, self-confidence, and adequate social support.
For those diagnosed with more than 1 disorder, it has been found
that the number of diagnosed psychological disorders is
positively related to the level of psychological distress [68] and
to suicidal ideation [3,4], whereas negatively related to patients’
level of self-confidence, quality of life [69,70], and social
support [71,72]. Therefore, any comorbidity factor scores should
adequately predict these validation variables.
Figure 1. Screenshot of Anxiety Online home page (now Mental Health Online).
Methods
Procedure
The Mental Health Online platform consists of 4 centers:
psychoeducational information, psychological screening and
assessment, online treatment, and health care practitioner
training. The psychoeducational center is a website that provides
psychoeducational information. The assessment center contains
the e-PASS. The treatment center provides and manages the 5
anxiety treatment programs and the more recent depression,
bulimia nervosa, and insomnia treatment programs. The training
center provides the eTherapist training programs and the health
care practitioner portal. The online psychological assessment
and referral program, e-PASS, includes a variety of demographic
and personal questions, the Kessler-6 [73], and the Suicidal
Warnings (ideation) measure, as well as the online diagnostic
program. Individuals can access the Mental Health Online
service from anywhere in the world provided they have an
Internet connection. People can complete e-PASS if they are
interested in the psychological assessment function and/or if
they are interested in online treatment. Those who want to
undertake the e-PASS are first required to register and consent
to the Mental Health Online terms and conditions [67]. The
procedures for collecting and reporting the Anxiety Online data
were approved by the Swinburne University Human Research
Ethics Committee.
Diagnostic Assessment
Based on an individual’s response to some of the e-PASS
questions, a person may be given a primary diagnosis and/or
multiple secondary diagnoses. Primary or secondary diagnosis
is determined by the reported presence of DSM-IV-TR symptoms
and the average score on severity scales, each of which assesses
the level of distress and interference caused by the symptoms
of a particular disorder. A total of 21 clinical disorders are
assessed by the e-PASS (see [65,66] for more details).
The disorder-specific severity score is the average of the scores
on 6 questions that assess how distressed and how many of the
symptoms of a given disorder interfere in one’s life. For
example, an individual who meets the diagnostic
symptomatology of PD has to rate each of the following
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questions on a scale from 0 indicating no distress or interference
to 8 indicating extremely severe distress or interference as
indicated subsequently:
Currently, how bothered or distressed are you by your panic
attack(s) and or worries about having another panic attack, and
or any changes in your behavior/routine because of these panic
attacks, in each of the following areas of your life:
1. Everyday living (eg, shopping, cleaning the house, preparing
food)
2. Social (eg, meeting friends or family, forming/maintaining
relationships)
3. Work or study (eg, attending work or classes, performing
tasks)
Currently, how much interference do your panic attack(s), and
or worries about having another panic attack, and or changes
in your behavior/routine because of these panic attacks cause,
in each of the following areas of your life:
1. Everyday living (eg, shopping, cleaning the house, preparing
food)
2. Social (eg, meeting friends or family, forming/maintaining
relationships)
3. Work or study (eg, attending work or classes, performing
tasks)
A person who does not endorse the initial DSM-IV-TR symptom
criteria questions for a particular disorder is not presented with
the questions assessing their level of distress and interference
of those symptoms and is assigned a severity score of zero.
Those who do endorse the initial DSM-IV symptom criteria
questions for a particular disorder are presented with the 6
distress and interference questions allowing the calculation of
a mean severity score ranging from 0 to 8. A mean distress and
interference severity score of 3.5 or greater is considered
sufficient to warrant a clinical diagnosis. Those whose mean
distress and interference severity scores are less than 3.5 are
considered to warrant a subclinical (or subthreshold) diagnosis.
The e-PASS diagnostic system was modeled after and informed
by the Anxiety Disorders Interview Schedule (ADIS) clinician
rating scale (Likert scale: 0=no symptoms, 4=mild presence of
the disorder, 8=very severe presence of the disorder). Most
“total scores” would not be a whole number because the system
used 6 rating scales and then averaged them. Consequently, the
final scores were rounded up or down to the nearest whole
number. Thus, a 4 is the typical score by a clinician using the
ADIS that indicates the “presence” of a disorder. However,
considering the decimal places resulting from the e-PASS
averaging of the 6 rating scales, those scoring 3.5 or more were
deemed clinical.
The psychometric properties of the e-PASS measures were
shown to have high test-retest reliability and reasonable
convergent validity with the structured clinical interviews (D
Nguyen, unpublished PhD thesis, Swinburne University, 2013).
However, the small sample size and some disagreement with
the structured clinical interviews in terms of the severity levels
required for a clinical diagnosis suggest that further validation
studies with large sample sizes are needed.
For the purpose of this work, we did not use the DSM-IV-TR
criteria for clinical diagnosis. Instead, we used the previously
described severity score without consideration of the level of
severity that would warrant clinical diagnosis. The average
severity scores provide the opportunity to examine the structure
of comorbidity of 21 psychological disorders based on a
dimensional scale that reflects information that covers
subthreshold to postthreshold diagnoses. This dimensional
approach should solve the problems of generalizability and
detection of the correlates of more severe mental disorders as
suggested by Krueger [7]. Also, the inclusion of subthreshold
symptomatology should avoid the risk of finding artifactual
explanations as was suggested by Wittchen et al [8].
Participants
A total of 13,414 individuals completed the e-PASS phase
between October 2009 and October 2012 and received at least
1 clinical diagnosis. The sample consisted of 3974 (29.63%)
males whose age ranged between 18-85 years with a mean of
36.88 (SD 12.59) years, and 9440 (70.37%) females whose ages
ranged between 18-86 years with a mean of 33.66 (SD 11.57)
years. A total of 749 (5.58%) participants received a clinical
diagnosis (severity score greater than 3.5) of only 1 disorder,
leaving 12,665 (94.42%) participants who were classified as
having a clinical or subclinical diagnosis for 2 or more of the
21 disorders assessed by e-PASS.
In this study, the score that each participant received before
treatment on the following variables were used to validate the
resulting comorbidity factors: Kessler-6 total score, suicidal
ideation, adequate social support (“Do you feel you have
adequate level of social support or engagement in social and/or
community activities?”), self-confidence (“Please rate your
overall level of self-confidence when it comes to managing your
own mental health”), and quality of life (“Please rate your
overall quality of life”). The suicidal ideation and adequate
social support measures were based on binary yes/no answer
responses. The level of self-confidence and the quality of life
measures were based on a Likert scale from “very poor” to “very
good.” For the purpose of this study, the last 2 measures were
converted to binary scale, with all those who gave a rating of
very poor and poor coded as zero and those who gave a rating
for good and very good coded as “1”.
Analysis
A series of principal component analyses were conducted to
develop new comorbidity factors from the severity scores
described previously. The descriptive statistics are reported for
the 21 severity scores and for the validation variables used to
validate the new comorbidity factors.
The pervasive nature of depression and anxiety disorders meant
that a typical factor analysis was not appropriate for the
extraction of the comorbidity factors. In particular, it was not
appropriate to search for a simple structure for the loadings of
the severity scores on the final comorbidity factors. Instead, the
goal was to derive the underlying dimensions that explained as
much of the variation in the severity scores as possible while
recognizing the importance of depression and anxiety in the
majority of the comorbidity factors. The relative accuracy of
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the severity score measures suggested that a principal component
analysis (PCA) should be used to construct the comorbidity
factors, rather than factor analysis with principal axis factoring
or maximum likelihood extraction of factors. This choice was
supported when comparative analyses performed with maximum
likelihood and principal axis factoring extraction methods failed
to produce results supported in the literature.
Monte Carlo simulation (parallel analysis) [74] was carried out
to determine the optimum number of components at each step,
based on the work of O’Connor [75]. Initially an oblimin
rotation was applied to the factors, allowing correlation between
the resulting comorbidity factors, but when these correlations
were found to be very weak, the oblimin rotation was replaced
by a varimax rotation ensuring that the resulting comorbidity
factors were independent of each other. At each step of the
analysis, disorders that loaded weakly on all factors were
removed.
In the second part of the analysis, comorbidity factor scores
were validated using linear and logistic multiple regression to
test their relationships with psychological distress (as measured
by the Kessler-6), suicidal ideation, adequate social support,
self-confidence, and quality of life. All analyses were carried
out using SPSS version 20 (IBM Corp, Armonk, NY, USA).
Results
Principal Component Analysis
The number of clinical diagnoses among those who received
more than 1 diagnosis ranged from 1 to 16 with a mean of 5.07
(SD 2.41). The number of diagnoses was significantly and
positively correlated with the psychological distress Kessler-6
total score (r=.54, P<.001), negatively with quality of life
(r=–.32, P<.001), negatively with self-confidence (r=–.29,
P<.001), and negatively with level of adequate social support
(r=–.24, P<.001). The 21 disorders and all descriptive statistics
are shown in Table 1. The validation variables and their
descriptive statistics are shown in Table 2.
Table 1. The frequency of severity of 21 psychological disorders.
Mean (SD)Severity of disorder
(N=13,414)
e-PASS Assessment
SubclinicalClinical
Psychological disorders, n (%)
1.43 (2.21)1809 (13.49)2970 (22.14)Panic disorder (PD) with or without agoraphobia
0.61 (1.47)1447 (10.79)1107 (8.25)Agoraphobia without a history of PD
1.92 (2.20)4031 (30.05)3504 (26.12)Social anxiety disorder (SAD)
1.10 (1.86)3055 (22.77)1823 (13.59)Specific phobia
2.35 (2.28)4366 (32.55)4464 (33.28)Generalized anxiety disorder (GAD)
0.74 (1.52)2730 (20.35)1033 (7.70)Obsessive-compulsive disorder (OCD)
0.96 (1.74)2974 (22.17)1461 (10.89)Posttraumatic stress disorder (PTSD)
2.63 (2.34)4188 (31.22)5131 (38.25)Major depressive episode (MDE)
0.02 (0.31)64 (0.48)41 (0.31)Anorexia nervosa
0.46 (1.46)931 (6.94)804 (5.99)Bulimia nervosa
0.21 (0.89)682 (5.08)316 (2.36)Binge eating disorder
Substance dependence
0.14 (0,63)839 (6.25)127 (0.95)Cannabis
0.07 (0.44)492 (3.67)48 (0.36)Stimulants
0.05 (0.34)313 (2.33)29 (0.22)Opioids
0.18 (0.65)1218 (9.08)104 (0.78)Sedatives
0.38 (0.96)2201 (16.41)321 (2.39)Alcohol dependence
0.09 (0.70)51 (0.38)179 (1.33)Somatization disorder
0.71 (1.79)649 (4.84)1503 (11.20)Body dysmorphic disorder
0.07 (0.42)457 (3.41)49 (0.37)Problem/pathological gambling
2.20 (2.23)4546 (33.89)4049 (30.18)Insomnia
0.53 (1.50)827 (6.17)1060 (7.90)Hypersomnia
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Table 2. The frequency of and descriptive statistics of the validation variables.
Mean (SD)Frequency (N=13,414)Validation variables
5079 (3.86)Suicidal ideation (yes), n (%)
6877 (51.27)Quality of life (high), n (%)
6024 (44.91)Adequate social support (high), n (%)
3888 (28.98)Self-confidence (high), n (%)
17.49 (4.90)Pre-Kessler-6 (total score)
All but 6 of 210 severity score correlations among disorder pairs
were positive, and all but 11 of 210 correlations were statistically
significant (P<.05). The Kaiser-Meyer-Olkin (KMO) of 0.80
confirmed that there was sufficient correlation in the data to
warrant a PCA analysis of this nature.
To determine the optimum number of comorbidity factors, both
methods of Monte Carlo simulation, random data and
permutation, indicated the presence of 4 underlying dimensions,
as suggested by the literature review. Disorders that loaded
weakly (<.3) on all factors were removed which resulted in the
removal of problem/pathological gambling, somatization
disorder, and binge eating disorder because none of these
disorders featured prominently in the comorbidity literature.
The resulting PCA model accounted for 42.9% of the total
variance in the remaining 18 severity scores when an oblimin
rotation was used. However, the component correlation matrix
showed all correlations to be less than .3 in absolute value,
suggesting that a simpler solution with 4 distinct comorbidity
factors was possible with a varimax rotation.
The penultimate 4-component model indicated that the fourth
component consisted of a negative loading of PD with or without
agoraphobia (–.59) and a positive loading of agoraphobia
without a history of PD (.86). This was a reflection of the mutual
exclusivity of these 2 classifications. That is, according to
DSM-IV-TR, a person can only be diagnosed with 1 or the other
but not both of these disorders at the same time. Also, although
a KMO of 0.8 was indicative of the suitability of the dataset for
factor analysis, examination of the anti-image of the correlation
matrix revealed that the measures of sampling adequacy for
each individual variable ranged from 0.69 to 0.91 except for
the agoraphobia without a history of PD, which was rather poor
at 0.4 suggesting that this variable should be removed. For these
reasons, it was decided to remove agoraphobia without a history
of PD from the analysis and develop a new model.
After removing agoraphobia without a history of PD, the KMO
value increased to 0.85 and a new 4-component model emerged
accounting for 43.9% of the variance in severity scores. As
shown in Table 3, the final 4-component model based on a
varimax rotation provided support for the 4 comorbidity factors
suggested by the literature. The first component included anxiety
disorders (specific phobia, PD with or without agoraphobia,
GAD, SAD, PTSD, and OCD) with MDE and insomnia having
the highest loading on this anxiety-depression factor. The second
component showed moderate loadings for alcohol and other
drug dependency–related disorders (stimulant dependence,
cannabis dependence, opioid dependence, alcohol dependence,
and sedative dependence) confirming the existence of a
substance abuse comorbidity factor. The third component
exhibited high to moderate positive loadings for bulimia nervosa,
BDD, anorexia nervosa, and OCD, confirming the presence of
a body image–eating factor. The fourth component showed high
to moderate positive loadings for MDE, insomnia, and
hypersomnia, confirming the existence of a depression-insomnia
comorbidity factor.
J Med Internet Res 2014 | vol. 16 | iss. 10 | e248 | p.7http://www.jmir.org/2014/10/e248/
(page number not for citation purposes)
AL-Asadi et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Table 3. Component weights for principal component analysis with varimax rotation.
ComponentDisorder severity
Depression–sleep prob-
lems
Body image–eatingSubstance abuseAnxiety-depression
.715Specific phobia
.695PD with or without agoraphobia
.654GAD
.622SAD
.509.541MDE
.537PTSD
.454.481Insomnia
.356.424OCD
.638Stimulant dependence
.596Cannabis dependence
.513Opioid dependence
.499Sedative dependence
.493Alcohol dependence
.791Bulimia nervosa
.705BDD
.408Anorexia nervosa
.745Hypersomnia
Comorbidity Factor Scores
Principal component scores representing these 4 comorbidity
factors were calculated for each participant. The first component
represents the anxiety-depression comorbidity factor. The second
component represents the substance abuse comorbidity factor.
The third component represents the body image–eating
comorbidity factor. The fourth component represents the
depression–sleep problems comorbidity factor.
The 4 comorbidity factor scores were then tested for their
relationships with the validation measures. These uncorrelated
factor scores served as the independent variables for multiple
regression analysis with the Kessler-6 total score serving as the
dependent variable. The results are shown in Table 4. The
regression coefficients for the 4 comorbidity scores were positive
and statistically significant (P<.001), explaining 44% of the
variation in the Kessler-6 total score.
Table 4. Results of regression analysis for the comorbidity factor scores and Kessler-6 total score
R 2RPt 1SEBComorbidity factors
.44.66
.00178.4.032.49Anxiety-depression
.00113.6.030.43Substance abuse
.00130.5.030.97Body image–eating
.00157.1.031.81Depression–sleep problems
In addition, these comorbidity factor scores were related to 4
other variables: suicidal ideation, adequate social support,
self-confidence, and quality of life using binary logistic
regression as shown in Table 5. The final binary logistic
regressions with forward selection resulted in significant odds
ratios for all 4 comorbidity factor scores. On average, increased
odds for experiencing suicidal ideation of 108%, 36%, 48%,
and 91%; for inadequate social support of 71%, 10%, 16%, and
49%; for having low self-confidence of 30%, 13%, 52%, and
64%; and for poor quality of life of 31%, 22%, 33%, and 81%
for each additional point scored on anxiety-depression, substance
abuse, body image–eating, and depression–sleep problems
factors, respectively.
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Table 5. Binary logistic regression for suicidal ideation, inadequate social support, low self-confidence, and poor quality of life in relation to comorbidity
factor scores.
OR (95% CI)PWald (df=1)Comorbidity factors
Suicidal ideation
2.08 (1.99-2.17).0011139.11Anxiety-depression
1.36 (1.30-1.42).001177.48Substance abuse
1.48 (1.42-1.54).001338.30Body image–eating
1.91 (1.83-2.00).001886.34Depression–sleep problems
0.59.001688.91Constant
Inadequate social support
1.71 (1.64-1.78).001650.90Anxiety-depression
1.10 (1.06-1.14).00121.65Substance abuse
1.16 (1.11-1.20).00155.50Body image–eating
1.49 (1.43-1.55).001377.74Depression–sleep problems
1.28.001183.94Constant
Low self-confidence
2.30 (2.17-2.44).001805.52Anxiety-depression
1.13 (1.08-1.19).00123.41Substance abuse
1.52 (1.43-1.61).001198.49Body image–eating
1.64 (1.56-1.73).001335.03Depression–sleep problems
3.07.0012287.57Constant
Poor quality of life
2.31 (2.20-2.42).0011267.24Anxiety-depression
1.22 (1.17-1.27).00177.36Substance abuse
1.33 (1.27-1.38).001174.99Body image–eating
1.81 (1.74-1.89).001710.34Depression–sleep problems
1.02.420.66Constant
These results confirm that the 4 comorbidity factor scores are
associated with the validation variables that are commonly
associated with psychological distress, thereby providing some
validation for these underlying dimensions of comorbidity.
Discussion
Initial Structure
Using the scores on dimensional scales measuring the severity
of 21 psychological disorders, the underlying structure of
comorbidity of these disorders was examined using the method
of PCA. Somatization disorder, pathological gambling, and
binge eating disorder were systematically removed from analysis
because of weak loadings of less than 0.3 on all components.
The penultimate model consisted of 4 components, the last of
which consisted of only a negative loading for PD with or
without agoraphobia and a positive loading for agoraphobia
without a history of PD, reflecting the mutual exclusivity of
these 2 diagnoses. According to DSM-IV-TR, a person can only
be diagnosed with 1 or the other but not both disorders at the
same time. This also suggests that there are differences between
the 2 groups even though the 2 groups share common etiological
factors. This finding is consistent with the finding of Katz et al
[63], but is contrary to the new DSM-5 criterion that no longer
allows agoraphobia without PD. However, Katz et al [63] found
a negative relationship between PD with or without agoraphobia
and agoraphobia without a history of PD, but Krueger [7] found
a positive relationship between these 2 disorders. In view of
these previous findings and the high component loadings for
only these 2 disorders on our fourth component, we removed
agoraphobia without a history of PD producing a new factor
model containing 17 disorders loading on 4 reconfigured
components.
Comorbidity Structure
The underlying dimensional structure of the 17 psychological
disorders consisted of 4 factors that accounted for 43.9% of the
total variance. The first comorbidity factor, labeled
anxiety-depression, consisted of all anxiety disorders (specific
phobia, PD with or without agoraphobia, GAD, SAD, PTSD,
and OCD) with MDE and insomnia. The second comorbidity
factor, labeled substance abuse, consisted of alcohol and
substance dependency disorders (alcohol dependence, cannabis
dependence, stimulant dependence, opioid dependence, and
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sedative dependence). The third comorbidity factor, labeled
body image–eating, consisted of body image and eating
problems (bulimia nervosa, BDD, anorexia nervosa, and OCD).
The fourth comorbidity factor, labeled depression–sleep
problems consisted of MDE, insomnia, and hypersomnia. It is
important to note that these comorbidity factors are unlikely to
be a reflection of the inability of these dimensional severity
scales to adequately distinguish between the different disorders.
It is the lack of correlation between these 4 factors that suggests
that these clusters of disorders are distinct rather than the
severity scales lacking the specificity to distinguish between
these disorders.
We should also emphasize here that we are not aware of any
work on comorbidity or the structure of comorbidity of
psychological disorders in the context of online programs.
Therefore, this work may be the first in addressing this area.
Consequently, we are comparing the results of this study with
results based on using in-clinic samples. Although there is no
logical reason to expect the comorbidity of psychological
disorders to be different for an online population from an
in-clinic population, caution is warranted.
These results are generally supportive of Krueger’s model [7].
The substance abuse factor corresponds with Krueger’s
externalizing factor minus the antisocial personality disorder
(not included in our data). The fact that all alcohol and drug
dependency classifications are highly loaded on 1 factor implies
that they may be largely determined by a single latent dimension.
This finding is consistent with the work of Katz et al [63] who
suggested that alcohol and drug dependency have a common
latent dimension and the work of Slade et al [64] who concluded
that alcohol dependency consisted of 1 latent dimension.
The anxiety-depression factor corresponds with Krueger’s
internalizing factor [7]. However, our results do not support the
separation of the internalizing factor into anxious-misery
(depression, dysthymia, GAD) and fear (SAD, specific phobia,
agoraphobia, PD) subfactors [7]. This could be due to the
differences between our dataset and Krueger’s dataset [7]. Our
results are based on 17 disordered classifications that were
assessed on dimensional scales that included subthreshold scores
whereas Krueger’s data [7] were based on 10 disorders that
were assessed on scales that relied exclusively on threshold
diagnoses.
It has long been known that anxiety disorders tend to be
comorbid with depression as well as each other. Our results are
consistent with this notion that anxiety disorders and depression
share many common symptoms. The inclusion of insomnia in
this group of disorders is understandable because it is often the
case that people who are suffering from insomnia are also
suffering from 1 or more anxiety and/or mood disorders [21,22].
This assertion becomes even clearer when we consider the
depression-sleep problem factor. Insomnia and hypersomnia
are sometimes associated with increases in anxiety and
depression [23-25]. Although insomnia or hypersomnia could
be symptoms of anxiety or mood disorders, they could also lead
to the experience of anxiety and/or depressive symptoms.
The body image-eating factor consists of disorders that are
related to the perception of body image. People suffering from
these disorders are not satisfied with the way they look, but each
group deals with this dissatisfaction differently. The inclusion
of OCD with these disorders is understandable and was
predicted. Sufferers of eating disorders and body dysmorphic
disorder share excessive concerns and preoccupation about
physical appearance coupled with dissatisfaction with their
bodies that commonly lead them to develop a distorted
self-image. The anxiety-provoking obsessive thoughts about
their appearance force them to engage in ritualistic behaviors
to reduce their anxiety. This pattern of anxiety-provoking
obsessive thoughts reduced by ritualistic-like behaviors is typical
of OCD sufferers. Those with eating disorders obsess over their
body weight and engage in behaviors that reduce their weight,
such as limiting food intake, vigorous exercises, and using
laxatives and/or forced purging. Those with BDD obsess over
their appearance and engage in behaviors that reassure them,
such as frequently checking with others in mirrors, comparing
themselves to others, camouflaging themselves, and seeking
cosmetic surgeries. These results are consistent with findings
of Allen and Hollander [55] and Cororve and Gleaves [56], and
with the finding of Rauch et al [57] who indicated that the same
brain structures were implicated in BDD and OCD, and Phillips
[58] who suggested that treatment for OCD is useful for BDD.
However, it should be noted that, aside from OCD, our results
do not support the existence of an eating-anxiety comorbidity
factor.
Finally, now that the DSM-5 has been introduced, there will be
a need to revise the e-PASS assessment tool based on the new
criteria. This revision will likely be needed for all diagnostic
measures and for other previous comorbidity research. However,
for some disorders, such as MDE and PD with or without
agoraphobia, this revision should be none to very minor
considering that the criteria changed very little or not at all. For
other disorders, such as PTSD for which the criteria have
undergone more changes, this revision may be more substantial.
Therefore, comorbidity and the clusters that make up the various
comorbidity structures will require reinvestigation as well, but
we would expect little change for disorders for which the criteria
have not changed considerably.
Validation of Comorbidity Factors
The 4 comorbidity factor scores, anxiety-depression, substance
abuse, body image-eating, and depression-sleep problems were
related to several variables: suicidal ideation, adequate social
support, quality of life, self-confidence, and the Kessler-6 total
score. As expected, the regressions of all 6 dependent variables
on the 4 comorbidity factors were statistically significant. The
greater the comorbidity factor scores the greater the Kessler-6
total score (the greater the psychological distress). A search of
various psychological databases revealed very little about the
association between psychological distress and current
comorbidity other than 1 study which found a positive
association between them [68]. Another study that was more
focused on adults with seizures also found a positive relationship
between psychiatric and physical comorbidities and
psychological distress [76]. It should be noted that most of the
variation in the Kessler-6 total score was accounted for by the
anxiety-depression factor, which is expected because of the
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direct relationship between Kessler-6 measures and measures
of depression and anxiety.
As expected, the odds for having inadequate social support
increased in likelihood for each additional point an individual
scored on anxiety-depression, substance abuse, body
image-eating, and depression-sleep problems factors,
respectively. This is indeed expected because social relationships
(involving social network composition, social support, social
interaction frequency and quality, and the experience of isolation
and loneliness) have long been linked with longevity and mental
and physical health. Social support helps people to cope more
adaptively with acute and chronic stress, thus potentially
enhancing allostasis and autonomic nervous system (ANS)
reactivity and related emotional regulation. Poor ANS reactivity
and emotional dysregulation are generally considered core
factors associated with many mental health conditions. Mazzella
et al [71] concluded that mortality progressively increased with
low social support and greater comorbidity, and that low social
support progressively increased with increasing comorbidity in
the elderly. Rockhill et al [72] found lack of social support
mediated the association between symptoms and lower grades
for adolescents with depression alone and comorbid symptoms.
We did not find many studies that examined the direct
relationship between social support and current comorbidity.
As expected, the odds for having low self-confidence to deal
with one’s mental health issues increased in likelihood for each
additional point an individual scored on anxiety-depression,
substance abuse, body image–eating, and depression–sleep
problems factors, respectively. These results suggest that greater
comorbidity factor scores reduce self-confidence in one’s ability
to deal with mental health issues. We are not aware of any study
that directly examined the relationship between comorbidity of
psychological disorders and patients’ perceived confidence in
dealing with their mental health issues.
As expected, the odds for having poor quality of life increased
in likelihood for each additional point an individual scored on
anxiety-depression, substance abuse, body image-eating, and
depression-sleep problems factors, respectively. Several studies
have shown a reduced health-related quality of life for patients
with physical comorbidities [76-79]. Fewer studies have also
found a negative relationship between comorbidity and quality
of life in specific populations, such as obese or bipolar patients
[69,70]. But we are not aware of any study that directly
examined psychological comorbidity and general quality of life.
It should not be surprising to find a negative relationship
between comorbidity factor scores and the general rating of
one’s quality of life. The same mechanisms that result in reduced
quality of life for patients with physical comorbidities should
also produce reduced quality of life for those with psychological
comorbidity.
As expected, the odds for experiencing suicidal ideation
increased in likelihood for each additional point an individual
scored on anxiety-depression, substance abuse, body
image-eating, and depression-sleep problems factors,
respectively. These results are particularly important and useful
because they suggest that comorbidity factor scores on all scales
have the potential to be used for the purpose of identifying those
with suicidal ideation, especially for those with high scores on
the anxiety-depression factor. However, more work is needed
to validate the potential use of these factor scores. These results
are consistent with the findings of Albert et al [3] and Schoevers
et al [4] who argued that comorbidity was consistently related
to higher rate of suicide.
There are very few studies published on the relationships
between current psychological comorbidity and measures such
as general psychological distress, self-confidence in dealing
with one’s mental health, adequate social support, and quality
of life. Future studies should further explore the relationships
between these measures. The fact that we used only 1 simple
question to measure these variables is a limitation of this study
that places a constraint on the generalization of findings. A
second limitation is that the e-PASS depends exclusively on
automated self-report to assess and determine the diagnoses of
participants. Andersson and Titov [80] raised some concerns
about the use of an online assessment tool for the purpose of
diagnosing individuals. Thirdly, there is only 1 study that
examined the psychometric properties of the e-PASS (D
Nguyen, unpublished PhD thesis, Swinburne University, 2013).
More studies with larger samples and more established measures
for comparisons based on the newly released DSM-5 are needed
before definitive conclusions can be made. A fourth limitation
is that the 4 factors only managed to explain 44% of the total
variance in the severity scores. This analysis needs to be
repeated and a confirmatory factor analysis may be conducted
on a new dataset collected since October 2012 to demonstrate
the generalizability of this model.
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